<DOC>
	<DOCNO>NCT02404298</DOCNO>
	<brief_summary>Chronic inflammatory demyelinate polyradiculoneuropathy ( CIDP ) immune-mediated disorder peripheral nerve . Intravenous immunoglobulin ( IVIg ) first line therapy CIDP . The investigator use transcriptomic approach compare gene expression profile peripheral blood patient CIDP autoimmune disease , IVIg treatment , order identify mechanism action condition , lead well understanding CIDP pathophysiology , potentially determine factor associate response treatment .</brief_summary>
	<brief_title>Transcriptome Analysis Peripheral Blood CIDP</brief_title>
	<detailed_description>We study change : - gene profile transcriptome analysis peripheral blood - T cell repertory - igG dosage - immunological profile Before IVIG ( T1 time ) 3 week IVIg treatment ( T2 time ) . On population patient : CIDP , autoimmune muscular disease , Clarkson syndrome , autoimmune disease . We also search polymorphism FCgammareceptor , TKPC et CASP3 gene CIDP patient</detailed_description>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Polyradiculoneuropathy</mesh_term>
	<mesh_term>Polyradiculoneuropathy , Chronic Inflammatory Demyelinating</mesh_term>
	<criteria>Inclusion criterion : Age â‰¥ 18 year old Obtained informed consent Patient definite probable CIDP accord EFNS/PNS criterion atypical CIDP corresponding patient EFNS/PNS clinical criterion least two EFNS/PNS supportive criterion Or Patient muscular autoimmune disease , Clarkson syndrome autoimmune disease Currently treat IVIG Exclusion criterion : pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Transcriptome analysis</keyword>
	<keyword>peripheral blood</keyword>
	<keyword>chronic inflammatory demyelinate polyradiculoneuropathy</keyword>
	<keyword>auto immune disease</keyword>
	<keyword>IVIg</keyword>
</DOC>